ImmunityBio, Inc.
IBRX
$8.66
$0.455.42%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -351.40M | -348.62M | -367.09M | -409.10M | -413.56M |
| Total Depreciation and Amortization | 15.43M | 15.80M | 16.30M | 16.83M | 17.55M |
| Total Amortization of Deferred Charges | 100.00K | 5.01M | 11.21M | 17.04M | 22.59M |
| Total Other Non-Cash Items | 85.27M | 58.87M | 38.51M | 42.64M | 1.61M |
| Change in Net Operating Assets | -54.33M | -50.76M | -48.48M | -37.56M | -19.42M |
| Cash from Operations | -304.94M | -319.70M | -349.56M | -370.16M | -391.24M |
| Capital Expenditure | -3.85M | -5.05M | -7.11M | -6.75M | -6.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -145.96M | -178.49M | 69.96M | 34.25M | -5.36M |
| Cash from Investing | -149.80M | -183.54M | 62.85M | 27.51M | -12.25M |
| Total Debt Issued | 2.88M | 0.00 | 0.00 | 96.96M | 96.96M |
| Total Debt Repaid | -1.16M | -16.00K | -26.00K | -43.00K | -64.00K |
| Issuance of Common Stock | 400.78M | 454.77M | 296.99M | 176.31M | 190.20M |
| Repurchase of Common Stock | -2.27M | -2.48M | -2.63M | -2.80M | -5.47M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 3.00K | 0.00 |
| Cash from Financing | 400.24M | 452.28M | 294.34M | 270.42M | 281.63M |
| Foreign Exchange rate Adjustments | 15.00K | 3.00K | 70.00K | 6.00K | -23.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.48M | -50.96M | 7.70M | -72.23M | -121.88M |